| Literature DB >> 28763584 |
Sonja Ständer1, Claudia Zeidler1, Matthias Augustin2, Gudrun Bayer3, Andreas E Kremer4, Franz J Legat5, Peter Maisel6, Thomas Mettang7, Martin Metz8, Alexander Nast9, Volker Niemeier10, Ulrike Raap11, Gudrun Schneider12, Hartmut F Ständer13, Petra Staubach14, Markus Streit15, Elke Weisshaar16.
Abstract
Associated with a host of different diseases, pruritus is a cardinal symptom that poses an interdisciplinary diagnostic and therapeutic challenge. Over time, that symptom may progress independently of the initial cause, thus losing its function as a warning sign and turning into a clinically relevant disease of its own. In Germany, approximately 13.5 % of the general population are affected by chronic pruritus, with an incidence of 7 %. All forms of chronic pruritus require targeted treatment consisting of (a) diagnosis and management of the underlying disease, (b) dermatological treatment of primary or secondary (for example, dry skin, scratch lesions) symptoms, (c) symptomatic antipruritic treatment, and (d) psychological/psychotherapeutic treatment in case of an underlying or associated psychological or psychosomatic condition. Medical care of patients with chronic pruritus should therefore include an interdisciplinary approach, in particular with respect to diagnosis and therapy of the underlying disease as well as in terms of the management of treatment and adverse events. The objective of the present interdisciplinary guidelines is to define and standardize diagnostic and therapeutic procedures in patients with chronic pruritus. This is a short version of the current S2 guidelines on chronic pruritus. The long version may be found at www.awmf.org.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28763584 DOI: 10.1111/ddg.13304
Source DB: PubMed Journal: J Dtsch Dermatol Ges ISSN: 1610-0379 Impact factor: 5.584